Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?

Laustsen, Andreas H; Johansen, Kristoffer; Engmark, Mikael; Andersen, Mikael R

View / Open Files

Published version (PDF, 1Mb)

Authors

Laustsen, Andreas H

Johansen, Kristoffer

Engmark, Mikael

Andersen, Mikael R

Publication Date

2017-02-03

Journal Title

PLoS neglected tropical diseases

ISSN

1935-2727

Volume

Issue

Pages

e0005361

Language

eng

Type

Article

This Version

VoR

Physical Medium

Electronic-eCollection

Metadata

Show full item record

Citation

Laustsen, A. H., Johansen, K., Engmark, M., & Andersen, M. R. (2017). Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?. PLoS neglected tropical diseases, 11 (2), e0005361. https://doi.org/10.1371/journal.pntd.0005361

Keywords

Humans, Snake Bites, Recombinant Proteins, Antivenins, Immunologic Factors, Costs and Cost Analysis, Africa South of the Sahara, Neglected Diseases

Identifiers

External DOI: https://doi.org/10.1371/journal.pntd.0005361

This record's URL: https://www.repository.cam.ac.uk/handle/1810/271749

Rights

Attribution 4.0 International

Licence URL: http://creativecommons.org/licenses/by/4.0/

The following licence files are associated with this item:

Creative Commons

Except where otherwise noted, this item's licence is described as Attribution 4.0 International